Isotopically labelledBenztropine-13C-d3 MesylateCat. No. P-B039-002Family · Pharmaceutical analytical standards
Benzatropine
A centrally acting anticholinergic with antihistamine activity, approved in the United States in 1954: it is used in parkinsonism and dystonia and to reduce movement disorders caused by antipsychotics. This family brings together labelled standards and other impurities.
Did you know?A large-scale screen of known molecules found that it makes oligodendrocytes mature, the cells that produce myelin: in animal models of multiple sclerosis it promoted remyelination.
Isotopically labelledBenztropine-13C-d3 MesylateCat. No. P-B039-002
Isotopically labelledBenztropine-d5Cat. No. P-B039-003
Isotopically labelledN-Desmethyl Benztropine-d5Cat. No. P-B039-004
ImpurityBenztropine HBrCat. No. P-B039-005CAS 6148-20-5
ImpurityBenztropine MesylateCat. No. P-B039-006CAS 132-17-2
ImpurityN-Desmethyl Benztropine HClCat. No. P-B039-007CAS 25471-67-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.